Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Coupa Partners With PayPal To Offer New Payment Solutions

Published 06/26/2019, 09:28 PM
Updated 07/09/2023, 06:31 AM

Coupa Software Inc. (NASDAQ:COUP) announced collaboration with PayPal (NASDAQ:PYPL) by which Coupa Pay users can access their PayPal account, which in turn will enhance customer experience.

The latest integration enables Coupa Pay users with more flexibility when paying PayPal-enabled suppliers, consequently ensuring hassle-free and secure online payment experience for buyers and suppliers.

Coupa Pay solution offers an optimized “one-stop-shop” for the company’s all B2B payment processing and transaction thereby increasing visibility and control. We believe the integration is aimed at providing significant better experience for customers, with more spending volume on their credit and debit cards, lower operational costs and improved security.

Per Ravi Thakur, senior vice president of business acceleration at Coupa, “As a leading global brand and payments innovator, PayPal will provide our community of buyers and suppliers the flexibility, simplicity, and security they need to pay and get paid smarter."

The partnership between Coupa Pay and PayPal reflects the ongoing hybrid ecosystem in payment methods, wherein companies are reluctant to miss out on business owing to rigidity in check-out options.

The companies are integrating their respective payment portals to provide seamless online experience to end-users. These initiatives are anticipated to bolster growth of transactional revenues and strengthen partner base.

What Investors Needs to Know

The Coupa Pay-PayPal partnership is expected to strengthen the presence of both the companies in the digital payment market, currently projected to hit $7.64 trillion by 2024 from approximately $3.42 trillion in 2018, per ResearchAndMarkets.

The move will make the payment process lot easier and quicker. By offering seamless payment option, PayPal’s account adoption will improve which in turn will aid growth of its transactional revenues. Further, this will strengthen the company’s partner base.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This move is also expected to bolster user base of Coupa services. Additionally, it will augment Coupa’s payment services which will help the company to gain competitive edge in the market.

Notably, the stock has returned 89.2% on a year-to-date basis, substantially outperforming the industry’s rally of 30.6%.

Last Words

Coupa Software is benefiting from expanding customer base on the back of growing adoption of spend management platform. This is likely to help drive subscription services revenues and gross margin.

The company’s expanding relationship with Amazon (NASDAQ:AMZN) Web Services (AWS) bodes well. The deal will enable customers to easily configure their AWS account to send invoices into Coupa Software's platform for touchless digital processing. This move provides greater visibility and efficiency in IT cloud spending.

Further, Coupa Software is benefiting from expanding customer base on the back of growing adoption of spend management platform. Moreover, an improving partner base is anticipated to drive the top line.

Zacks Rank & Key Picks

Coupa currently carries a Zacks Rank #4 (Sell).

Some better-ranked stocks in the broader technology sector are Match Group, Inc. (NASDAQ:MTCH) and Autohome Inc. (NYSE:ATHM) , each flaunting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Match Group and Autohome have a long-term earnings growth rate of 15.2% and 20.9%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Autohome Inc. (ATHM): Free Stock Analysis Report

Match Group, Inc. (MTCH): Free Stock Analysis Report

PayPal Holdings, Inc. (PYPL): Free Stock Analysis Report

COUPA SOFTWARE (COUP): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.